Does Flossing Prevent Alzheimer’s Disease?

No clinical trial has ever tested whether flossing prevents Alzheimer’s disease, so the honest answer is that nobody knows for certain. What researchers have established is a chain of associations that makes the idea biologically plausible: gum disease is linked to higher Alzheimer’s risk, a key gum-disease bacterium has been found inside Alzheimer’s-affected brains, and flossing reduces the load of that bacterium between your teeth. Each link in that chain is real, but the chain has not been tested end to end, and several alternative explanations remain in play.

The Link Between Gum Disease and Alzheimer’s Risk

Multiple large studies have found that people with chronic periodontitis, the severe form of gum disease that damages the bone supporting your teeth, develop Alzheimer’s at higher rates than people without it. A retrospective cohort study using national health-insurance data found that ten years of chronic periodontitis raised the risk of Alzheimer’s by about 70 percent after adjusting for other health factors.¹ Another retrospective study reported that periodontitis roughly doubled dementia risk even among people who otherwise maintained healthy lifestyles.² A systematic review found that having periodontitis at baseline was associated with a six-fold increase in the rate of cognitive decline over a six-month follow-up period.³

These are associations, not proof that one causes the other. But the numbers are large enough and consistent enough across different study designs that researchers have spent the past decade trying to figure out whether gum disease is genuinely doing something to the brain or whether the two conditions simply share common risk factors like aging, smoking, and diabetes.

A Gum Bacterium Found Inside Alzheimer’s Brains

The most striking piece of evidence involves a specific microbe. Porphyromonas gingivalis, the bacterium most responsible for destructive gum disease, has been identified in brain tissue from people who died with Alzheimer’s. A landmark 2019 study detected the bacterium itself and its signature toxins, called gingipains, in brain samples from Alzheimer’s patients. The levels of those toxins correlated with the severity of tau tangles and other hallmark brain pathology.⁴ Autopsy studies have also found evidence of the bacterium in cerebrospinal fluid of people diagnosed with Alzheimer’s.⁵

A meta-analysis pooling data from multiple studies found that the presence of oral bacteria in brain tissue was associated with roughly a ten-fold increase in Alzheimer’s risk, and the presence of P. gingivalis specifically was associated with about a six-fold increase.⁶ That sounds dramatic, but these numbers come from cross-sectional brain studies comparing people who already had Alzheimer’s to those who did not. They tell you the bacterium is there more often in affected brains; they cannot tell you it arrived before the disease started.

How Gum Bacteria Might Reach and Damage the Brain

For this connection to be more than a coincidence, oral bacteria would need a way to get from inflamed gums into brain tissue. Researchers have identified at least three routes, none of them mutually exclusive.

The most direct route involves the blood-brain barrier, the tight layer of cells that normally keeps pathogens out of the brain. Lab studies have shown that toxins from P. gingivalis, particularly a component of its outer membrane called lipopolysaccharide, weaken this barrier. In a human cell-based model, exposure to these bacterial products reduced the barrier’s electrical resistance and impaired its ability to recover.⁷ Other experiments have shown that the bacterium increases barrier permeability through specific molecular pathways.⁸ A more recent study found that the same bacterial toxin increased blood-brain barrier permeability in live animals, with measurable decreases in tight-junction proteins.⁹

The second route is systemic inflammation. Chronic gum disease pumps inflammatory signals into the bloodstream for years. That low-grade, persistent inflammation contributes to neuroinflammation in the brain.¹⁰ The third route runs through the gut: swallowed oral bacteria can disrupt the gut lining and alter the gut microbiome. In animal experiments, P. gingivalis administered by mouth was detected in the intestines within hours and triggered changes in gut bacteria, increased intestinal permeability, and eventually neuroinflammation.¹¹

What Happens When the Bacterium Reaches Brain Cells

Animal and laboratory experiments suggest that once P. gingivalis or its toxins reach the brain, they can trigger changes that look like Alzheimer’s. In one striking study, wild-type mice, animals not genetically engineered to develop Alzheimer’s, were given the bacterium orally for several months. Their brains developed hallmarks of the disease: amyloid-beta plaques, phosphorylated tau protein, neurofibrillary tangles, and neuroinflammation. Control mice showed none of these changes.¹² A separate study in middle-aged mice confirmed this pattern and added that the exposed animals performed worse on memory and behavioral tests.¹³

At the cellular level, the bacterium’s gingipain toxins degrade tau protein and increase its phosphorylation, a key step in the formation of the tangles that destroy brain cells in Alzheimer’s.¹⁴ There is also a counterintuitive twist: the amyloid-beta protein that forms the plaques characteristic of Alzheimer’s appears to function as an antimicrobial weapon. Experiments have shown that amyloid-beta kills bacteria with a potency comparable to natural immune peptides, and brain tissue from Alzheimer’s patients shows higher antimicrobial activity that correlates with amyloid-beta levels.¹⁵ In mouse and worm models, amyloid-beta fibrils trapped and agglutinated microbial cells in a net-like structure, essentially sacrificing brain health to fight the infection.¹⁶ If this model is correct, some Alzheimer’s pathology could be the brain’s own immune system overreacting to a chronic bacterial invasion.

What Flossing Actually Does to the Bacteria That Matter

All of the above raises an obvious question: if P. gingivalis and gum disease are part of the story, and if flossing fights gum disease, does that mean flossing protects the brain? Here the evidence gets thinner but remains suggestive.

A twin study that compared flossing twins to non-flossing twins over two weeks found that the non-flossing group had significantly higher levels of periodontal pathogens between their teeth, including P. gingivalis specifically, along with other disease-associated species. The flossing group, by contrast, had a microbial community more consistent with gum health.¹⁷ Population-level data tell a similar story: adults who flossed more than once a week had about 17 percent lower odds of having periodontitis after adjusting for other factors, though no additional benefit was seen from flossing more often than that.¹⁸

One wrinkle: a 12-week clinical trial measuring the actual plaque microbiome found that adding flossing to brushing did not produce a statistically significant difference in bacterial communities compared to brushing alone, while brushing combined with mouthrinse did show significant changes.¹⁹ That does not mean flossing is useless; interdental cleaning targets different surfaces than brushing, and the twin study focused specifically on the bacteria living between teeth. But it does suggest that flossing’s effect on the overall oral microbiome is more modest than many people assume. The honest answer is that flossing shifts the specific bacterial neighborhood between your teeth in a healthier direction, and that neighborhood happens to be where P. gingivalis thrives.

Interdental Brushes and Water Flossers

If you find traditional flossing awkward, other interdental tools may do the job as well or better for plaque removal. A trial comparing dental floss, interdental brushes, and water flossers in children found that oral irrigators and interdental brushes were each significantly more effective than toothbrushing alone at removing plaque, while floss was not statistically different from brushing by itself.²⁰ A randomized trial in adults with implant-supported crowns found that all three methods improved plaque control, with the water flosser showing a slight reduction in an inflammatory marker while floss and interdental brushes showed slight increases.²¹ The takeaway for Alzheimer’s prevention, such as it is, does not hinge on whether you use string floss versus a brush or irrigator. What matters is disrupting the bacterial communities that live between your teeth, by whatever method you will actually do consistently.

The Reverse Causality Problem

One of the biggest reasons scientists hesitate to call this relationship causal is the possibility that it runs backward. People in the early stages of cognitive decline often struggle with complex self-care routines. Flossing and thorough brushing are among the first habits to deteriorate when memory and coordination falter. So it is plausible that early, undiagnosed dementia causes poor oral health rather than the other way around. A 2025 review in the Journal of Dental Research highlighted this problem, noting that even studies designed to address reverse causality by tracking people over time failed to account for cognitive function before the study began.²²

There is also the confounding of shared risk factors. Socioeconomic disadvantage, smoking, diabetes, and limited access to healthcare all increase the risk of both gum disease and dementia. A large cohort study found that poor oral health was associated with more than a two-fold increase in Alzheimer’s risk, with tooth loss showing the strongest association at roughly a three-fold increase.²³ But even after propensity-score matching for age, sex, and multiple lab measures, the survival curves converged, illustrating how much of the raw association might be explained by factors other than gum disease itself. These confounders are extremely difficult to fully separate from a genuine causal effect.

Genetic Susceptibility and APOE4

Not everyone’s brain may be equally vulnerable to oral bacteria. The APOE4 gene variant, already the strongest known genetic risk factor for late-onset Alzheimer’s, appears to interact with gum disease in troubling ways. Mice engineered to carry the APOE4 variant and then given experimental periodontitis showed greater loss of neurons in the hippocampus, the brain region critical for memory, compared to controls.²⁴ Other animal studies found that APOE4 mice infected with P. gingivalis had bacterial DNA detectable in their brains, suggesting the genetic variant makes the blood-brain barrier more permeable to oral pathogens. APOE-deficient mice also developed progressive, age-related leaking of their blood-brain barrier without any infection at all.²⁵

In humans, a scoping review found a correlation between gingival inflammation and cognitive impairment specifically in APOE4 carriers, and higher levels of the APOE4 protein were found in the gum-crevice fluid of patients who had both Alzheimer’s and periodontitis.²⁶ If these findings hold up, people who carry APOE4 might have even more reason to take aggressive care of their gums, though this idea remains speculative and has not been tested in a prevention trial.

The Drug That Tried to Break the Chain

Perhaps the most telling chapter in this story involves a drug designed to directly block the connection. A company developed atuzaginstat (COR388), a small-molecule inhibitor that targeted the gingipain toxins produced by P. gingivalis. The logic was straightforward: if gingipains in the brain contribute to Alzheimer’s pathology, blocking them should slow the disease. A phase 1 trial in healthy elderly people and Alzheimer’s patients showed the drug was well tolerated, with no severe side effects. But the larger phase 2 GAIN trial, which enrolled 643 patients with mild to moderate Alzheimer’s, was halted by the FDA due to dose-dependent liver toxicity.²⁷ Before it was stopped, preliminary results hinted that patients who tested positive for P. gingivalis DNA in their mouths were more likely to benefit from the drug, which at least suggests the mechanism is not imaginary.²⁸ The trial’s failure was a setback for the hypothesis, though it was a safety problem rather than a proof that the underlying idea was wrong.

Early Signs That Treating Gum Disease Helps Cognition

While no trial has tested whether periodontal treatment prevents Alzheimer’s specifically, a few small studies have looked at whether treating gum disease improves brain function. One study measured brain activity using near-infrared spectroscopy before and after initial periodontal treatment and found increased activity in the prefrontal cortex and language areas during cognitive tasks after treatment.²⁹ Another study found that scaling and root planing, the deep cleaning used to treat periodontitis, reduced a neurochemical marker linked to excitotoxicity and was associated with small improvements in processing speed and executive function.³⁰ These studies are small and short-term, but they suggest that calming inflammation in the gums has measurable effects beyond the mouth.

Why Clinical Guidelines Have Not Caught Up

Given the volume of research linking periodontal disease to cognitive decline, you might expect medical guidelines for dementia care to include oral-health assessments. They largely do not. A scoping review of clinical practice guidelines found that dementia care was addressed by only one eligible guideline, which focused on caregiver training and comfort care rather than prevention. The authors noted a clear gap between the evidence linking gum disease and tooth loss to cognitive decline and the actual clinical pathways used in geriatric and long-term care settings.³¹ The disconnect is partly because the evidence, while substantial, remains observational. Without a randomized trial showing that treating gum disease actually reduces Alzheimer’s incidence, guideline committees are reluctant to make formal recommendations.

Oral Microbiome Profiling as a Potential Diagnostic Tool

An intriguing offshoot of this research involves using the mouth as a window into Alzheimer’s risk. When researchers profiled the oral microbiomes of Alzheimer’s patients and compared them to cognitively healthy controls, they found distinct differences. The predominant bacterium in the periodontal microbiome of Alzheimer’s patients was P. gingivalis, and the relative abundance of another species, Veillonella parvula, was significantly elevated in both saliva and gum-crevice fluid from Alzheimer’s patients.³² This is very preliminary work and nowhere near becoming a screening test. But the idea that a simple saliva sample could flag elevated risk is worth watching, especially since oral sampling is noninvasive and cheap compared to brain imaging or spinal fluid analysis.

The bigger picture for anyone wondering whether their flossing habit might protect their brain is this: the biological plausibility is genuinely compelling, the epidemiological signal is consistent, and the animal data are hard to dismiss. But the causal chain from “you floss tonight” to “you lower your Alzheimer’s risk decades from now” has not been proven. What has been shown is that flossing reduces the specific pathogen most implicated in the gum-brain connection, that gum disease worsens cognitive decline in people who already have it, and that treating gum disease produces at least short-term cognitive benefits. Those are good enough reasons to floss, even if the Alzheimer’s prevention story is still being written.